Molecular Assays for the Diagnosis of Cutaneous Melanoma (DL39373) - Published for Review and Comments

This proposed Local Coverage Determination (LCD) has been published for review and comments for contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Medicare Coverage Database (MCD) Number: DL39373

LCD Title: Molecular Assays for the Diagnosis of Cutaneous Melanoma

Comment period: July 07, 2022 - August 20, 2022

Visit the CMS MCD to access Proposed LCDs not released to final LCDs.

Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.

            Last Updated Tue, 12 Jul 2022 13:24:29 +0000